Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Therapeutic application of monoclonal antibodies in multiple sclerosis.
The use of laboratory gait analysis for understanding gait deterioration in people with multiple sclerosis.
Longitudinal extensive transverse myelitis and Zika virus: A diagnostic challenge in a hospital in Colombia.
One handed intermittent self-urinary catheterism with an adaptive equipment: Case report of an amputee patient suffering from multiple sclerosis.
A Hedonism Hub in the Human Brain.
CYP4F2 affects phenotypic outcome in adrenoleukodystrophy by modulating the clearance of very long-chain fatty acids.
Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.
Supramaximal Stimulus Intensity as a Diagnostic Tool in Chronic Demyelinating Neuropathy.
Simulated microgravity enhances oligodendrocyte mitochondrial function and lipid metabolism.
Relevance of biomarkers in disease progression in multiple sclerosis.
The 5-HT₆ serotonin receptor antagonist SB-271046 attenuates the development and expression of nicotine-induced locomotor sensitisation in Wistar rats.
Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis.
AMP-Activated Protein Kinase Suppresses Autoimmune Central Nervous System Disease by Regulating M1-Type Macrophage-Th17 Axis.
Renin-angiotensin system gene expression and neurodegenerative diseases.
The Effect of Glatiramer Acetate on Spinal Cord Volume in Relapsing-Remitting Multiple Sclerosis.
T-bet promotes the accumulation of encephalitogenic Th17 cells in the CNS.
Lubrini et al.'s study, "The contribution of depressive symptoms to slowness of information processing in relapsing remitting multiple sclerosis".
Immunogenicity of Torpedo acetylcholine receptor in the context of different rat MHC class II haplotypes and non-MHC genomes.
The influence of sulthiame on EEG in children with benign childhood epilepsy with centrotemporal spikes (BECTS).
Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor Cells.
Neurotrophins' Modulation by Olive Polyphenols.
Reduced fecal GABA levels in multiple sclerosis patients.
Intra-CNS activation by antigen-specific T lymphocytes in experimental autoimmune encephalomyelitis.
Absence of Tau triggers age-dependent sciatic nerve morphofunctional deficits and motor impairment.
Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology.
Pages
« first
‹ previous
…
709
710
711
712
713
714
715
716
717
…
next ›
last »